Daesung Microbiological Labs. Co., Ltd. (KOSDAQ: A036480)
Health Care · Biotechnology · KR
₩6,170.00
-0.64% today · -20.6% 1Y
Daesung Microbiological Labs. Co., Ltd. (KOSDAQ: A036480) operates in the Biotechnology industry within the Health Care sector. The company is valued at $16.92M.
Over the last twelve months the share price has lost 20.6%, trading between 5.40K and 10.96K.
Tweenvest scores Daesung Microbiological Labs. Co., Ltd. across four factors: quality 51/100, value 57/100, dividend 19/100. Its strongest factor is value.
A036480 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.92M
- Revenue (TTM)
- $16.99M
- P/E
- 35.87
- EPS
- 172.03
- Dividend yield
- 1.22%
- Beta (5Y)
- 0.08
- 52-week high
- ₩10,960.00
- 52-week low
- ₩5,400.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.80M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €864.20 | -4.19% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $138.89 | -4.26% |
Figures last refreshed Aug 18, 2026.